Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
Dubois S, Mareschal S, Picquenot JM, Viailly PJ, Bohers E, Cornic M, Bertrand P, Veresezan EL, Ruminy P, Maingonnat C, Marchand V, Lanic H, Penther D, Bastard C, Tilly H, Jardin F. Dubois S, et al. Among authors: marchand v. Oncotarget. 2015 Jun 30;6(18):16712-24. doi: 10.18632/oncotarget.3154. Oncotarget. 2015. PMID: 25762637 Free PMC article.
Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas.
Rizzo D, Viailly PJ, Mareschal S, Bohers E, Picquenot JM, Penther D, Dubois S, Marchand V, Bertrand P, Maingonnat C, Etancelin P, Feuillard J, Bastard C, Tilly H, Jardin F, Ruminy P. Rizzo D, et al. Among authors: marchand v. Am J Hematol. 2017 Jan;92(1):68-76. doi: 10.1002/ajh.24584. Am J Hematol. 2017. PMID: 27737507 Free article.
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Dubois S, Viailly PJ, Bohers E, Bertrand P, Ruminy P, Marchand V, Maingonnat C, Mareschal S, Picquenot JM, Penther D, Jais JP, Tesson B, Peyrouze P, Figeac M, Desmots F, Fest T, Haioun C, Lamy T, Copie-Bergman C, Fabiani B, Delarue R, Peyrade F, André M, Ketterer N, Leroy K, Salles G, Molina TJ, Tilly H, Jardin F. Dubois S, et al. Among authors: marchand v. Clin Cancer Res. 2017 May 1;23(9):2232-2244. doi: 10.1158/1078-0432.CCR-16-1922. Epub 2016 Dec 6. Clin Cancer Res. 2017. PMID: 27923841
Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.
Bobée V, Ruminy P, Marchand V, Viailly PJ, Abdel Sater A, Veresezan L, Drieux F, Bérard C, Bohers E, Mareschal S, Dubois S, Jais JP, Leroy K, Figeac M, Picquenot JM, Molina TJ, Salles G, Haioun C, Tilly H, Jardin F. Bobée V, et al. Among authors: marchand v. J Mol Diagn. 2017 Nov;19(6):892-904. doi: 10.1016/j.jmoldx.2017.07.007. Epub 2017 Oct 17. J Mol Diagn. 2017. PMID: 29054399 Free article.
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Bohers E, Viailly PJ, Becker S, Marchand V, Ruminy P, Maingonnat C, Bertrand P, Etancelin P, Picquenot JM, Camus V, Menard AL, Lemasle E, Contentin N, Leprêtre S, Lenain P, Stamatoullas A, Lanic H, Libraire J, Vaudaux S, Pepin LF, Vera P, Tilly H, Jardin F. Bohers E, et al. Among authors: marchand v. Blood Cancer J. 2018 Aug 1;8(8):74. doi: 10.1038/s41408-018-0111-6. Blood Cancer J. 2018. PMID: 30069017 Free PMC article.
CD70: A Potential Target in Breast Cancer?
Petrau C, Cornic M, Bertrand P, Maingonnat C, Marchand V, Picquenot JM, Jardin F, Clatot F. Petrau C, et al. Among authors: marchand v. J Cancer. 2014 Oct 22;5(9):761-4. doi: 10.7150/jca.10360. eCollection 2014. J Cancer. 2014. PMID: 25368676 Free PMC article.
Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM Study.
Mareschal S, Ruminy P, Bagacean C, Marchand V, Cornic M, Jais JP, Figeac M, Picquenot JM, Molina TJ, Fest T, Salles G, Haioun C, Leroy K, Tilly H, Jardin F. Mareschal S, et al. Among authors: marchand v. J Mol Diagn. 2015 Apr 9:S1525-1578(15)00046-X. doi: 10.1016/j.jmoldx.2015.01.007. Online ahead of print. J Mol Diagn. 2015. PMID: 25891505 Free article.
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma.
Bobée V, Drieux F, Marchand V, Sater V, Veresezan L, Picquenot JM, Viailly PJ, Lanic MD, Viennot M, Bohers E, Oberic L, Copie-Bergman C, Molina TJ, Gaulard P, Haioun C, Salles G, Tilly H, Jardin F, Ruminy P. Bobée V, et al. Among authors: marchand v. Blood Cancer J. 2020 May 22;10(5):59. doi: 10.1038/s41408-020-0322-5. Blood Cancer J. 2020. PMID: 32444689 Free PMC article. Clinical Trial.
Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia.
Ruminy P, Marchand V, Buchbinder N, Larson T, Joly B, Penther D, Lemasle E, Lepretre S, Angot E, Mareschal S, Viailly PJ, Dubois S, Clatot F, Viennot M, Bohers E, Rizzo D, Cornic M, Bertrand P, Girod C, Camus V, Etancelin P, Buchonnet G, Schneider P, Picquenot JM, Vannier JP, Bastard C, Tilly H, Jardin F. Ruminy P, et al. Among authors: marchand v. Leukemia. 2016 Mar;30(3):757-60. doi: 10.1038/leu.2015.177. Epub 2015 Jul 3. Leukemia. 2016. PMID: 26139430 No abstract available.
197 results